Abstract:A novel series of peptidomimetic aldehydes was designed and synthesized to target 3C protease (3Cpro) of enterovirus 71 (EV71). Most of the compounds exhibited high antiviral activity, and among them, compound 18p demonstrated potent enzyme inhibitory activity and broad-spectrum antiviral activity on a panel of enteroviruses and rhinoviruses. The crystal structure of EV71 3Cpro in complex with 18p determined at a resolution of 1.2 Å revealed that 18p covalently linked to the catalytic Cys147 with an aldehyde group. In addition, these compounds also exhibited good inhibitory activity against the 3CLpro and the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially compound 18p (IC50 = 0.034 μM, EC50 = 0.29 μM). According to our previous work, these compounds have no reasons for concern regarding acute toxicity. Compared with AG7088, compound 18p also exhibited good pharmacokinetic properties and more potent anticoronavirus activity, making it an excellent lead for further development.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02258?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02258</a>.An overlay of EV71 3Cpro-18p and AG7088 complex structures; the binding pocket of 3Cpro of CoXB3, RV-A02, and EV71; the anti-SARS-CoV-2 activities of compounds; the 1H NMR and 13C NMR spectra of target compounds; the purity of target compounds; and the crystallography data collection and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02258/suppl_file/jm0c02258_si_001.pdf">PDF</a>)Molecular formula stings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02258/suppl_file/jm0c02258_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

3D-Quantitative Structure-Activity Relationship Study for the Design of Novel Enterovirus A71 3C Protease Inhibitors

Synthesis and Structure–activity Relationship of Α-Keto Amides As Enterovirus 71 3C Protease Inhibitors

Structure–activity Relationship Study of Peptidomimetic Aldehydes As Enterovirus 71 3C Protease Inhibitors

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2

3D-QSAR Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulation Toward Identifying Lead Compounds for NS2B-NS3 Protease Inhibitors.

Cyanohydrin As An Anchoring Group For Potent And Selective Inhibitors Of Enterovirus 71 3c Protease

Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Simulation Analysis Study.

Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71

Cyanohydrin As an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.

Novel Alkynylamide-Based Nonpeptidic Allosteric Inhibitors for SARS-CoV-2 3-Chymotrypsin-like Protease

Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor

Design and bioassay of non-peptidic inhibitors of SARS coronavirus 3C-like proteinase

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Biochemical Characterization of Recombinant Enterovirus 71 3C Protease with Fluorogenic Model Peptide Substrates and Development of a Biochemical Assay

Exploring the Potential of Vortioxetine Derivatives As Inhibitors of SARS‐CoV‐2 Main Protease: A Computational Study

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

Structural insight into EV-A71 3A Protein and Its Interaction with a Peptide Inhibitor

Design, synthesis and biological activity evaluation of novel allosteric inhibitors of the DENV NS2B–NS3 protease

4-Iminooxazolidin-2-one As a Bioisostere of the Cyanohydrin Moiety: Inhibitors of Enterovirus 71 3C Protease

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

Exploring the Efficacy of Noncovalent SARS‐CoV‐2 Main Protease Inhibitors: A Computational Study Incorporating Design, ADMET, Molecular Dynamics Simulation, and DFT Analysis